PCR: H1 2025 saw lower revenue, profit, and EBITDA amid volatile markets and resilient liquidity

About this update from Pcc Rokita Spolka Akcyjna

Revenue and net profit declined year-over-year in H1 2025, with EBITDA down 29%. All major segments saw lower earnings, and the group faced ongoing market volatility and supply chain risks, but maintained strong liquidity and met all debt covenants.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for Pcc Rokita Spolka Akcyjna